Novel Ketoconazole-Loaded Niosomal Gel with Carbamide for Enhanced Topical Delivery and Skin Hydration in Fungal Infections

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Prajitha Biju, Manjunath M. Shenoy, Rouchelle Tellis, Ramesh Bhat, Ranajit Das, Ashwini Prabhu, Mohammed Gulzar Ahmed, Vivek Ghate
{"title":"Novel Ketoconazole-Loaded Niosomal Gel with Carbamide for Enhanced Topical Delivery and Skin Hydration in Fungal Infections","authors":"Prajitha Biju,&nbsp;Manjunath M. Shenoy,&nbsp;Rouchelle Tellis,&nbsp;Ramesh Bhat,&nbsp;Ranajit Das,&nbsp;Ashwini Prabhu,&nbsp;Mohammed Gulzar Ahmed,&nbsp;Vivek Ghate","doi":"10.1007/s12247-024-09916-9","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Atopic dermatitis is a condition, wherein the outermost skin layer is disrupted, leading to excessive water loss and cutaneous lesions. This study assesses an antifungal topical formulation utilizing a vesicular system loaded with ketoconazole and a hydrating agent to treat fungal skin infections while preventing resistance and recurrence.</p><h3>Methods</h3><p>The Central Composite Design in Design Expert software was used to optimize ketoconazole-loaded niosomes, with vesicle size and drug entrapment efficiency as dependent variables and surfactant and organic solvent concentrations as independent variables. The optimized formulation was evaluated against predicted values, and compatibility and stability were analyzed via FT-IR and differential scanning calorimetry. Niosome morphology was examined using light microscopy and SEM. Niosomes were incorporated into a hydrogel containing 5% carbamide, a pH stabilizer, and preservative to enhance dermal bioavailability. The gel underwent evaluations for viscosity, antifungal activity, <i>in vitro</i> drug release, <i>ex vivo</i> permeation, skin irritation, TEWL, and histopathology.</p><h3>Results</h3><p>Optimized niosomes had a vesicle size of 275 nm and 98.38% drug entrapment efficiency. The gel was translucent, non-sticky, had a viscosity of 18,200 mPa·s at 20 °C, and exhibited a sustained <i>in vitro</i> drug release. The release kinetics followed zero-order and Baker-Lonsdale models, with R<sup>2</sup> values of 0.94 and 0.99. Application on mice reduced moisture loss and improved skin barrier function.</p><h3>Conclusion</h3><p>The ketoconazole-loaded niosomal gel is a promising carrier for dermal drug delivery against fungal infections.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"20 2","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-024-09916-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Atopic dermatitis is a condition, wherein the outermost skin layer is disrupted, leading to excessive water loss and cutaneous lesions. This study assesses an antifungal topical formulation utilizing a vesicular system loaded with ketoconazole and a hydrating agent to treat fungal skin infections while preventing resistance and recurrence.

Methods

The Central Composite Design in Design Expert software was used to optimize ketoconazole-loaded niosomes, with vesicle size and drug entrapment efficiency as dependent variables and surfactant and organic solvent concentrations as independent variables. The optimized formulation was evaluated against predicted values, and compatibility and stability were analyzed via FT-IR and differential scanning calorimetry. Niosome morphology was examined using light microscopy and SEM. Niosomes were incorporated into a hydrogel containing 5% carbamide, a pH stabilizer, and preservative to enhance dermal bioavailability. The gel underwent evaluations for viscosity, antifungal activity, in vitro drug release, ex vivo permeation, skin irritation, TEWL, and histopathology.

Results

Optimized niosomes had a vesicle size of 275 nm and 98.38% drug entrapment efficiency. The gel was translucent, non-sticky, had a viscosity of 18,200 mPa·s at 20 °C, and exhibited a sustained in vitro drug release. The release kinetics followed zero-order and Baker-Lonsdale models, with R2 values of 0.94 and 0.99. Application on mice reduced moisture loss and improved skin barrier function.

Conclusion

The ketoconazole-loaded niosomal gel is a promising carrier for dermal drug delivery against fungal infections.

Graphical Abstract

Abstract Image

新型含脲酮康唑乳状体凝胶增强真菌感染的局部递送和皮肤水合作用
目的:特应性皮炎是一种皮肤最外层被破坏,导致过多水分流失和皮肤病变的疾病。本研究评估了一种局部抗真菌制剂,利用含有酮康唑和水合剂的囊泡系统治疗真菌皮肤感染,同时防止耐药性和复发。方法以囊泡大小和药物包封效率为因变量,表面活性剂和有机溶剂浓度为自变量,采用Design Expert软件中的中心复合设计优化酮康唑负载乳质体。通过FT-IR和差示扫描量热法对优化后的配方进行相容性和稳定性评价。用光镜和扫描电镜观察Niosome的形态。将乳小体掺入含有5%尿素、pH稳定剂和防腐剂的水凝胶中,以提高皮肤的生物利用度。凝胶进行了粘度、抗真菌活性、体外药物释放、体外渗透、皮肤刺激、TEWL和组织病理学的评估。结果优化后的纳米粒囊泡大小为275 nm,包封率为98.38%。凝胶呈半透明状,无粘性,在20℃下粘度为18200 mPa·s,具有体外持续释放的特点。释放动力学符合零级模型和Baker-Lonsdale模型,R2分别为0.94和0.99。应用于小鼠减少水分流失和改善皮肤屏障功能。结论酮康唑乳质体凝胶是一种很有前途的抗真菌感染真皮给药载体。图形抽象
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Innovation
Journal of Pharmaceutical Innovation PHARMACOLOGY & PHARMACY-
CiteScore
3.70
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories: Materials science, Product design, Process design, optimization, automation and control, Facilities; Information management, Regulatory policy and strategy, Supply chain developments , Education and professional development, Journal of Pharmaceutical Innovation publishes four issues a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信